Introduction
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, commonly found amongst the elderly.
1,2 Unfortunately, AD is still incurable and the underlying cause is also not yet known, which poses a grand challenge for the development of effective diagnostic tools and treatment for this devastating disease. 3, 4 An amyloid-b (Ab) plaque is one of the important pathological hallmarks in an AD brain, 5, 6 and a number of probes for imaging the Ab plaques as a biomarker have been reported over the years. Despite all of these efforts, only few contrast agents for various advanced molecular imaging techniques [7] [8] [9] [10] [11] have been approved for clinical diagnostics. In fact, the formation of Ab plaques in the brain reects a dynamic equilibrium and an interplay among the Ab monomers, oligomers and brils. 12 Studies indicate that the deposition of Ab plaques does not correlate with the disease progression of AD but soluble Ab oligomers are believed to play a detrimental role in the cause of the disease. 13 Thus, early diagnosis and intervention are much more crucial for delaying disease progression and preventing irreversible neuronal damage.
Increasing evidence suggests that soluble oligomeric Ab is a major cause of cytotoxicities such as induction of oxidative stress and elevations of intracellular [Ca 2+ ] in the pathological cascade of AD. 14, 15 In addition, Ab oligomers are more neurotoxic than insoluble Ab brils in the plaques, and are responsible for the dysfunction of neurotransmission, and the imbalance of neuronal excitability, eventually resulting in neuronal death and memory impairment. Ab oligomer formation and deposition could represent one of the appropriate biomarkers for early AD diagnosis; and their dynamic levels in the brain could be considered as one of the key indicators in evaluating the disease progression. 12, 16, 17 Thus, development of a reliable method to selectively detect Ab oligomers and suppress oligomer formation before the onset of clinical symptoms is highly desirable and benecial in early diagnostics and therapeutics of AD.
Nevertheless, chemical probes developed over the past decades mainly detected insoluble Ab species and had poor selectivity towards soluble Ab oligomers. 18, 19 This is due to the lack of guidelines for designing imaging probes for the selective recognition of soluble Ab oligomers because of the heterogeneous and transient nature of oligomers. Viola et al. have developed an MRI probe for selective recognition of Ab oligomers by incorporating oligomer-specic antibodies onto magnetic nanostructures. 20 On the other hand, uorescence imaging offers a rapid, real-time and sensitive diagnostic alternative, 21 which is powerful for monitoring the dynamic progress of Ab peptide aggregation and brillogenesis. Although a few Ab oligomer imaging probes have recently been reported, they are not effective and sensitive enough for Ab oligomer detection and imaging ex vivo and in vivo. For instance, BD-Oligo shows very poor BBB permeability and was applied only in the imaging of mature APP Â PS1 Tg mice.
22 AN-SP possesses only a moderate binding affinity to Ab oligomers.
23
In vivo detection of Ab oligomers in Tg mice at a young age when AD-like pathology is just forming has not yet been demonstrated. Thus, the development of an effective and reliable Ab oligomer targeting probe that is useful for multiple AD mouse models is still a great challenge.
Cyanine dye, a versatile class of turn-on uorescence probe for two-photon excited imaging, generally exhibits much stronger binding interactions with Ab brils than oligomers and monomers. 24, 25 We report herein our new ndings on an oligomer-selective cyanine probe, namely F-SLOH. With a uo-rine group incorporated into the cyanine lead structure, the probe remarkably becomes highly selective for Ab oligomeric assemblies with a high binding affinity over monomers or brils due to the strong hydrophobic and intermolecular hydrogen bonding interactions, as revealed by molecular docking calculations. Its in vivo application in labelling Ab oligomers was successfully demonstrated in 7 month-old APP/PS1 double Tg and APP/PS1/Tau triple Tg mouse models. Intriguingly, F-SLOH was found not only to show excellent blood-brain barrier penetrability, low bio-toxicity, and a good inhibitory effect on the self-aggregation of Ab monomers, but also to prevent Abinduced toxicities, making it highly useful for in vivo applications particularly for early diagnosis and treatment of AD.
Results and discussion
The synthesis of F-SLOH is outlined in Scheme S1 † and its structure (Fig. 1A) was conrmed by 1 H and 13 C NMR spectroscopy as well as high-resolution mass spectroscopy. The photophysical properties of F-SLOH are summarized in Fig. S1 . † The absorption and emission spectra showed a large Stokes shi up to 150 nm in PBS solution, which is favorable to avoiding self-absorption in bio-imaging. Although F-SLOH shows weak uorescence with very low quantum yield (F l¼488 nm ¼ 0.006 in PBS, F l¼488 nm ¼ 0.011 in DMSO), it exhibits different extents of uorescence enhancement towards the monomers, oligomers and brils accompanied by a substantial blue shi of the emission maximum upon an addition of various Ab 1-40 species (Fig. 1B) , which is attributed to the restricted rotation of the photo-excited dye upon binding to the Ab species, resulting in a reduction in the non-radiative decay. Intriguingly, F-SLOH exhibits a stronger uorescence enhancement upon binding to the Ab oligomers compared to binding to the monomers and brils, giving rise to an enhanced quantum yield of 0.26 which is higher than that of its parent compound, SLOH (F ¼ 0.12) (Fig. S2 †) . Favorably, F-SLOH affords very minor uorescence enhancement and negligible interference upon mixing/interacting with bovine serum albumin (BSA) and Tau protein, respectively. Considering that the viscosity of the biological medium was about 3.5 cP, which might result in the reduction of non-radiative decay, the effect of the viscosity on the uorescence of F-SLOH was also investigated. As shown in Fig. S3 , † the uorescence of F-SLOH in a solution of water-glycerol with a viscosity of 4.5 cP is indeed increased, but to a much smaller extent compared to that upon an addition of Ab. To quantify the binding affinity of Ab species, the dissociation constant (K d ) of F-SLOH was determined by uorescence titration (Fig. S4 †) and estimated from a Scatchard plot, yielding K d values of 3.22, 0.66, and 1.90 mM for the monomers, oligomers and brils, respectively (Fig. S5 †) . Such a low K d value for the oligomer (0.66 mM) indicated that F-SLOH possessed a signicantly stronger binding affinity towards Ab oligomers than monomers and brils. Furthermore, a good linearity was obtained in the enhanced uorescence as a function of the amount of Ab oligomers added to the F-SLOH solution ( Fig. S6 †) , suggesting its capability for quantitative analysis. In addition, the uorescence intensity of F-SLOH remains relatively constant over time and over a wide range of pH values (pH ¼ 4-10) (Fig. S7 †) , indicating its potential for practical applications.
The binding behavior of F-SLOH towards different sizes of Ab 1-40 species was also investigated. Different sizes of Ab species were prepared by incubating the monomer for different durations. Besides recording the emission spectra of F-SLOH, the growth process of Ab was monitored by ThT staining. As shown in Fig. 1C , there is a strong increase in the uorescence of F-SLOH upon binding with Ab, following incubation in the rst 2 h. Aer reaching a maximum at 2 h of incubation, the enhanced uorescence decreases in intensity with a longer period of incubation. In contrast, the uorescence of ThT increased hyperbolically with respect to the incubation time and became saturated when Ab was incubated for more than 10 h. These results clearly demonstrated that the uorescence enhancement of F-SLOH by Ab species is size-dependent and Ab oligomers afford a stronger uorescence enhancement than brils and monomers upon binding with F-SLOH. The morphology and size of Ab 1-40 at selected time points were conrmed by TEM (Fig. S8 †) and DLS (Fig. S9 †) , respectively. The size of the monomeric Ab 1-40 is $22 nm and it gradually increased to 196, 317, 567, and 712 nm aer incubation for 1, 2, 4, and 6 h, respectively (Fig. S7 †) . Thus, F-SLOH displayed a stronger uorescence enhancement upon binding with an Ab 1-40 oligomer with a size smaller than 300 nm.
The conrmational change of the Ab 1-40 species upon binding to F-SLOH was elucidated by circular dichroism (CD). As depicted in Fig. S10 , † when the monomeric form of Ab 1-40 underwent self-aggregation to the brillary form, the positive peak at 185 nm diminished and the negative peak showed an obvious red shi from 205 to 223 nm. Such changes indicated a conformational change of the monomeric Ab 1-40 from a random coil to a b-sheet and then aggregation to brils.
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Upon binding to F-SLOH, the peak distinctly shied with a decrease in amplitude. It is worth mentioning that the apparent change in the CD spectrum of the monomers upon incubating with F-SLOH supports the idea that F-SLOH is able to promote structural transformation during Ab 1-40 aggregation and inhibit oligomerization and brillation. The inhibition effect was further conrmed by a ThT uorescence assay. The seed-mediated growth of Ab in the presence of one equivalent of F-SLOH aer 12 h incubation exhibited no observable changes in size (Fig. S11 †) and nearly no uorescence response at the emission maximum of ThT (Fig. S12 †) , suggesting an effective inhibition effect of F-SLOH towards the Ab 1-40 monomers. More interestingly, we found that the growth was terminated instantly when F-SLOH was added at any time during the brosis process, by measuring the bril length (Fig. S13 †) . Ab is the most abundant species in an AD brain, while Ab 1-42 is considered as the most toxic form. 27 We also investigated the inhibition capability of F-SLOH on Ab 1-42 oligomerization by performing sodium dodecyl sulfate-poly-acrylamide gel electrophoresis (SDS-PAGE). The results shown in Fig. S14 † conrmed that negligible oligomers or brils were formed upon the addition of F-SLOH.
To gain insight into the structural features of F-SLOH for the selective binding to the Ab oligomer, we carried out quantum mechanical calculations of F-SLOH and SLOH (without Fsubstitution), followed by a molecular docking search and molecular dynamic simulation calculations for both of the assemblies of F-SLOH and SLOH with the Ab oligomer (Fig. S15 †) . Their optimized molecular structures were rst determined using quantum mechanical calculations at the B3LYP/6-31G* level (Fig. S15A and B †) . A well-known Ab trimer model from the RCSB database (PDB ID: 4NTR)
28 was adopted as the closest working model of an Ab oligomer available for the binding studies, although it may not completely represent the true picture of the oligomer structure. It was shown that the hydrophobic F19/V36 residues of the Ab oligomer constitute an oligomer specic binding site (Fig. S15C †) . 22, 23 This site would only be exposed to solvent in Ab oligomers but not in Ab brils. Such a unique structural feature of the Ab oligomer can be used to identify the specic oligomeric probe. As shown in Fig. S15D -G, † both molecules conform to a slightly twisted geometry to maximize the interactions with the Ab oligomer in which both carbazole moieties of SLOH and F-SLOH are well accommodated by the F19 residue in the Ab oligomer due to favorable pp stacking interactions. In the F-SLOH-Ab oligomer assembly, the quinolinium ring shows close contact with the hydrophobic domain of the Ab oligomer, and the hydroxyethyl chain on the quinolinium ring also forms a CH/O interaction with the side chain of the V36 residue. However, these types of interactions are not found in the complex of SLOH and the Ab oligomer. Meanwhile, the uorine substituent on the carbazole ring also gives rises to the CH/F interaction with the F19 side chain upon binding. As a result, the much higher affinity of F-SLOH towards the Ab oligomer could be attributed to the strong hydrophobic and intermolecular CH/O and CH/F interactions between F-SLOH and the Ab oligomer, offering important guidelines for designing Ab oligomer sensing probes.
The cytotoxicity was evaluated by MTT assays on SH-SY5Y cells. As shown in Fig. 2A , in the presence of F-SLOH, the cell viability is still maintained at a high level, in which its LC 50 was estimated to be 49 mM. In addition to being non-toxic, F-SLOH showed a pronounced neuroprotective effect on primary neuronal cells against Ab-induced toxicity. Fig. 2B shows that the toxicity induced by Ab and Ab 1-42 on primary hippocampus neuronal cells is largely reduced by $25-75% upon the addition of F-SLOH, leading to greatly enhanced cell viabilities. It is well-known that ROS generation and Ca(II) ion overloading are two of the toxic effects induced by Ab species. Here, we found that F-SLOH could reduce the ROS production induced by both Ab and Ab 1-42 on primary hippocampus neuronal cells. As depicted in Fig. 2C , F-SLOH reduces the level of ROS of primary hippocampus neuronal cells by 15-20% under coincubation with Ab 1-40 and Ab . Furthermore, as shown in Fig. 2D , Ab 1-42 would induce a signicant level of calcium inux into the neuron cells; however, the calcium uploading was almost reduced to half in the F-SLOH pre-treated primary neuronal cells, compared to that of the control. The excellent neuroprotective effect of F-SLOH against ROS generation and calcium inux further highlights its great potential for therapeutics of AD.
The practical application of F-SLOH for specic detection and labelling of Ab oligomers in Tg mouse brain tissue was investigated by colocalization studies. A triple Tg AD model (APP/PS1/Tau) was used to examine the colocalization of F-SLOH labelling and Ab or Tau immunoreactivity. When F-SLOH was incubated with brain slices of Tg and wild-type (WT) mice, distinct contrasts of the plaque-like uorescence images in the brain section of the Tg mouse, but little uores-cence in the WT brain, were observed (Fig. S16 †) . These results suggested that F-SLOH was able to label the Ab species in the AD Tg mouse model. Moreover, the growth in size and the counts of existing plaques in the Tg mice of the two age groups (7 month and 10 month) were obviously visualized (Fig. S17 †) . When the brain slices were co-stained with SLOH, F-SLOH and the Abbril tracker thioavin-S (Thio-S), remarkable differences were observed, in which SLOH and Thio-S only stained in the central core of the plaques while F-SLOH could label not only the core but also the peripheral areas of the plaques (Fig. S17 and S18 †) . In addition, the staining with Thio-S shows a higher degree of colocalization with SLOH than with F-SLOH. All these results indicate that F-SLOH is capable of staining the transient, unstable oligomer species present in the transition to bril elongation. The targeting selectivity towards oligomers of F-SLOH was further veried using various antibodies including an Ab oligomer-specic antibody (Ab-Oligo), Ab monomer antibodies (6E10 or 4G8), a total Ab antibody (pAb) and a conformational Tau antibody (MC1). Fig. 3 shows that the uorescence of F-SLOH exhibited excellent colocalization with the immunouorescence of Ab-Oligo. On the other hand, the stained areas of 4G8, 6E10 and pAb were much more extensive than those of Ab-Oligo and F-SLOH, due to the fact that these three antibodies recognize more forms of Ab. 4G8 and 6E10 also labelled a subset of neurons (arrowheads) where Ab monomers could be present. No overlay was found between the F-SLOH labelling and MC1 (for the Tau protein) immunouorescence. All these results consistently ascertained the specic staining ability of F-SLOH for Ab oligomers in the brain sections of AD mouse models.
The blood-brain barrier (BBB) permeability is a prerequisite for any in vivo applications. The index of lipophilicity (log P) of F-SLOH was rst determined to be 2.5 using the online ALOGPS 2.1 program. It is regarded as highly desirable for BBB penetration. The BBB permeability and the washout rate from the brain with F-SLOH were then investigated by in vivo imaging analysis. The 7 month-old AD Tg and age-matched WT mice as a control were injected with F-SLOH via the tail vein at a dosage of 5.0 mg kg À1 . As shown in Fig. S19A , † a remarkably bright uorescence signal of F-SLOH was observed in the brains of both the Tg and WT mice within 10 min, compared to that of the pre-injected mouse, indicating that F-SLOH was indeed BBB penetrable with a high initial brain uptake. The uorescence signals in the brain diminished signicantly over time, but the decline rate was considerably slower in the Tg mouse compared to that in the WT mouse. This was due to the presence of Ab species in the Tg mice which strongly bind to F-SLOH, leading to a decrease of outow rate. Then, the brain kinetic proles by semi-quantitative analysis of the uorescence images of the brains were estimated at a region of interest (ROI). Signicantly higher uorescence signals were consistently displayed in the Tg mouse compared to that of the WT mouse (P < 0.05) (Fig. S19B †) . The longer retention of F-SLOH in the Tg mice further supported its strong interactions with Ab species. Then, the brain slices of the F-SLOH-treated mice were harvested and imaged to further verify the brain penetration of F-SLOH. As shown in Fig. S20 , † the plaque-enhanced F-SLOH uorescence was clearly seen in the brain sections of the Tg mouse aer 2 h of injection with a decreased intensity aer 4 h of injection, whereas nearly no uorescence signal was seen in the WT mouse aer 2 h of injection. As compared with the reported oligomer probes, BD-Oligo and AN-SP, F-SLOH appears to have a much superior BBB penetrability. 22, 23 To further investigate the targeting specicity of F-SLOH towards Ab oligomers in vivo, the brain sections of the Tg mice were incubated with Thio-S and various antibodies. Consistently, Fig. 4 and Fig. S21 † showed that in vivo labelling of F-SLOH displayed a highly similar pattern/result to that obtained from in vitro studies, and further quantitative analysis, shown in Fig. 4L , demonstrated that the extent of colocalization between F-SLOH and Ab-Oligo reached approximately 90%, which is much higher than that of 6E10, 4G8, pAb, or Thio-S (around 50-65%), affirming the specicity of F-SLOH to Ab oligomers in vivo. Unlike other reported NIR imaging agents, F-SLOH was successfully applied to the in vivo detection of Ab oligomers in the Tg mice at the young age of 7 months, at which age AD-like pathology is just forming at a relatively early stage in this model, highlighting its tremendous potential applications in the early diagnosis of AD.
Conclusions
In summary, we have developed a novel uoro-substituted carbazole-based cyanine, namely F-SLOH, which exhibits a high binding affinity and selective recognition for Ab oligomers over monomers and brils. The strong binding selectivity, as revealed by molecular docking simulation calculations, resulted from the synergistic effect of strong p-p stacking and intermolecular CH/O and CH/F bonding interactions between F-SLOH and the Ab oligomer. These results highlight that the subtle structure modication (i.e. replacing H with an F atom) could cause dramatic changes in the functional and physical properties of a molecule. Importantly, F-SLOH also exhibited diverse desirable multifunctional properties for practical applications including excellent BBB penetrability, low bio-toxicity and strong uores-cence enhancement upon binding with Ab oligomers. Remarkably, in addition to the good inhibitory effect on Ab aggregation/ brillogenesis, F-SLOH can protect Ab-induced neuronal toxicity by means of inhibiting [Ca 2+ ] elevation and ROS generation. Furthermore, in vivo imaging of 7 month-old AD mice models further conrmed that the probe could target Ab oligomers and be washed out effectively from the brain. To the best of our knowledge, this is the rst report on a theranostic probe that shows specic and effective in vivo labelling of Ab oligomers and potent neuroprotective effects against Ab-induced toxicities. This probe offers promising potential as a useful theranostic agent in earlystage diagnostics and therapeutics of AD.
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